— Know what they know.
Not Investment Advice

PXYN OTC

Praxsyn Corporation
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -99.8% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 55 · $6347 mcap · 521M float · 0.103% daily turnover

Income Trends

Revenue
$81K -90.1% ▼
5Y CAGR: -44.8%
Gross Profit
$24K -93.8% ▼
Operating Income
-$196K +92.8% ▲
Net Income
-$566K +83.8% ▲
EPS (Diluted)
$-0.00 +83.3% ▲
EBITDA
-$139K +95.2% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2012FY2013FY2014FY2017FY2018
Revenue$0$7M$67M$819K$81K
YoY Growth-100.0%+0.0%+852.9%+0.0%-90.1%
Cost of Revenue$52K$694K$4M$433K$57K
Gross Profit$0$6M$63M$386K$24K
Gross Margin—90.1%94.6%47.1%29.4%
R&D Expenses$0$0$0$0$0
SG&A Expenses$2M$3M$37M$3M$220K
Operating Expenses$3M$3M$37M$3M$220K
Operating Income-$3M$3M$26M-$3M-$196K
Operating Margin—45.8%39.1%-331.3%-240.9%
Interest Expense$423K$2M$32M$582K$370K
Income Before Tax-$878K$770K-$13M-$3M-$566K
Tax Expense$2K$540K-$214K$0$0
Net Income-$1M$230K-$12M-$3M-$566K
Net Margin—3.3%-18.5%-426.8%-695.5%
EPS (Diluted)$-0.02$0.00$-0.05$-0.00$-0.00
EBITDA-$401K$3M$19M-$3M-$139K
Shares Outstanding71M176M269M725M739M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms